Drugs / 99mTc-PYP
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04899180 | Jul 2023 → Jan 2024 | amyloidosis, aortic valve stenosis | Mayo Clinic | Completed | No outcome recorded |
| Phase 0 | NCT03414632 | Dec 2017 → Mar 2020 | diastolic heart failure | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 99mTc-PYP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03414632 ↗ |
| Modality | Diagnostic / imaging agent | “Radioisotope used in the SPECT/CT imaging” NCT03414632 ↗ |